New Technology for Tissue Engineering

Novel programmable peptide-DNA technology simulates dynamic cell-extracellular matrix interactions that take place within the living cell and holds a lot of promise in treating Parkinson''s disease, stroke, arthritis and several diseases that require tissue regeneration, even more effectively in the future.

Programmable Peptide-DNA Technology to Promote Healing in Parkinson''s
- Current tissue engineering technologies have limited scope for tissue regeneration
- Novel technology mimics dynamic processes within living cell, promising more effective approach to treating diseases

Programmable Peptide DNA Hybrids- Potential Game Changer In Tissue Engineering Technology

Using peptide-DNA platform in tissue engineering applications closely replicates dynamic interactions taking place in vivo, not possible with existing methods. Read More

Related Links

Wildcard SSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

New Technology for Tissue Engineering

Programmable Peptide DNA Hybrids- Potential Game Changer In Tissue Engineering Technology

Related Links

How to Deal with a Stroke

Parkinsons Disease

Rheumatoid Arthritis

Follow Us On :